Metabolomic and Lipidomic Signatures of Metabolic Syndrome and Its Physiological Components in Adults: A Systematic Review

Overview

Journal Sci Rep

Specialty Science

Date 2020 Jan 22

PMID 31959772

Citations 61

Authors

Stephanie Monnerie

Blandine Comte

Daniela Ziegler

Jose A Morais

Estelle Pujos-Guillot

Pierrette Gaudreau

Affiliations

Soon will be listed here.

Abstract

The aim of this work was to conduct a systematic review of human studies on metabolite/lipid biomarkers of metabolic syndrome (MetS) and its components, and provide recommendations for future studies. The search was performed in MEDLINE, EMBASE, EMB Review, CINHAL Complete, PubMed, and on grey literature, for population studies identifying MetS biomarkers from metabolomics/lipidomics. Extracted data included population, design, number of subjects, sex/gender, clinical characteristics and main outcome. Data were collected regarding biological samples, analytical methods, and statistics. Metabolites were compiled by biochemical families including listings of their significant modulations. Finally, results from the different studies were compared. The search yielded 31 eligible studies (2005-2019). A first category of articles identified prevalent and incident MetS biomarkers using mainly targeted metabolomics. Even though the population characteristics were quite homogeneous, results were difficult to compare in terms of modulated metabolites because of the lack of methodological standardization. A second category, focusing on MetS components, allowed comparing more than 300 metabolites, mainly associated with the glycemic component. Finally, this review included also publications studying type 2 diabetes as a whole set of metabolic risks, raising the interest of reporting metabolomics/lipidomics signatures to reflect the metabolic phenotypic spectrum in systems approaches.

Citing Articles

Serum Lipidomic Analysis of T2DM Patients: A Potential Biomarker Study.

Qi W, Yang C, Li J, Bao L Diabetes Metab Syndr Obes. 2025; 18:529-539.

PMID: 39990177 PMC: 11847430. DOI: 10.2147/DMSO.S505863.

Correlations Between Gut Microbiota Composition, Medical Nutrition Therapy, and Insulin Resistance in Pregnancy-A Narrative Review.

Enache R, Rosu O, Profir M, Pavelescu L, Cretoiu S, Gaspar B Int J Mol Sci. 2025; 26(3).

PMID: 39941139 PMC: 11818759. DOI: 10.3390/ijms26031372.

Role of Milk Intake in Modulating Serum Lipid Profiles and Gut Metabolites.

Xu T, Zhang C, Yang Y, Huang L, Liu Q, Li L Metabolites. 2024; 14(12).

PMID: 39728469 PMC: 11676809. DOI: 10.3390/metabo14120688.

Fish in focus: Navigating organ damage assessment through analytical avenues - A comprehensive review.

Jerald I, Ravindran J, Babu M Toxicol Rep. 2024; 13:101841.

PMID: 39717851 PMC: 11665677. DOI: 10.1016/j.toxrep.2024.101841.

Unveiling Lipidomic Alterations in Metabolic Syndrome: A Study of Plasma, Liver, and Adipose Tissues in a Dietary-Induced Rat Model.

Petrovic S, Mouskeftara T, Paunovic M, Deda O, Vucic V, Milosevic M Nutrients. 2024; 16(20).

PMID: 39458462 PMC: 11509917. DOI: 10.3390/nu16203466.

References

Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

Alberti K, Zimmet P, Shaw J . Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006; 23(5):469-80. DOI: 10.1111/j.1464-5491.2006.01858.x. View

Day C . Metabolic syndrome, or What you will: definitions and epidemiology. Diab Vasc Dis Res. 2007; 4(1):32-8. DOI: 10.3132/dvdr.2007.003. View

Mottillo S, Filion K, Genest J, Joseph L, Pilote L, Poirier P . The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56(14):1113-32. DOI: 10.1016/j.jacc.2010.05.034. View

Beltran-Sanchez H, Harhay M, Harhay M, McElligott S . Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013; 62(8):697-703. PMC: 3756561. DOI: 10.1016/j.jacc.2013.05.064. View

Saklayen M . The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2):12. PMC: 5866840. DOI: 10.1007/s11906-018-0812-z. View

Nolan P, Carrick-Ranson G, Stinear J, Reading S, Dalleck L . Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis. Prev Med Rep. 2017; 7:211-215. PMC: 5540707. DOI: 10.1016/j.pmedr.2017.07.004. View

van Vliet-Ostaptchouk J, Nuotio M, Slagter S, Doiron D, Fischer K, Foco L . The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014; 14:9. PMC: 3923238. DOI: 10.1186/1472-6823-14-9. View

Kaur J . A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014; 2014:943162. PMC: 3966331. DOI: 10.1155/2014/943162. View

10.

Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills A, Misra A . Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health. 2017; 17(1):101. PMC: 5251315. DOI: 10.1186/s12889-017-4041-1. View

11.

Wilson P, DAgostino R, Parise H, Sullivan L, Meigs J . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005; 112(20):3066-72. DOI: 10.1161/CIRCULATIONAHA.105.539528. View

12.

Li C, Ford E . Definition of the Metabolic Syndrome: What's New and What Predicts Risk?. Metab Syndr Relat Disord. 2008; 4(4):237-51. DOI: 10.1089/met.2006.4.237. View

13.

Grundy S . Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012; 59(7):635-43. DOI: 10.1016/j.jacc.2011.08.080. View

14.

Poon V, Kuk J, Ardern C . Trajectories of metabolic syndrome development in young adults. PLoS One. 2014; 9(11):e111647. PMC: 4219745. DOI: 10.1371/journal.pone.0111647. View

15.

Steinbrecher A, Pischon T . The potential use of biomarkers in the prevention of Type 2 diabetes. Expert Rev Endocrinol Metab. 2019; 8(3):217-219. DOI: 10.1586/eem.13.11. View

16.

Nicholson J, Lindon J, Holmes E . 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999; 29(11):1181-9. DOI: 10.1080/004982599238047. View

17.

Liggi S, Griffin J . Metabolomics applied to diabetes-lessons from human population studies. Int J Biochem Cell Biol. 2017; 93:136-147. DOI: 10.1016/j.biocel.2017.10.011. View

18.

Zhang A, Qiu S, Xu H, Sun H, Wang X . Metabolomics in diabetes. Clin Chim Acta. 2013; 429:106-10. DOI: 10.1016/j.cca.2013.11.037. View

19.

cajka T, Fiehn O . Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics. Anal Chem. 2015; 88(1):524-45. DOI: 10.1021/acs.analchem.5b04491. View

20.

Duarte I, Diaz S, Gil A . NMR metabolomics of human blood and urine in disease research. J Pharm Biomed Anal. 2014; 93:17-26. DOI: 10.1016/j.jpba.2013.09.025. View